Hour24 News
Sophisticated and simple
-
Strategic Partnership Aims to Accelerate Next-Generation Fusion Protein Programs HanchorBio, Inc., a global clinical-stage biotechnology company focused on next-generation immunotherapies for oncology and autoimmune diseases,…
-
Harbour BioMed and Lannacheng Forge a Long-Term Strategic Collaboration Harbour BioMed has entered into a long-term strategic collaboration with Lannacheng to accelerate the discovery and…
-
Overview of the Collaboration Galux, a South Korean biotechnology company pioneering artificial intelligence in protein therapeutics discovery, has announced a research agreement with Boehringer Ingelheim.…
